RX-1 Sleep
Vivaquant, Inc. Dba Rhythm Express · Decision date Jun 22, 2026
What did the FDA decide?
FDA records K253148 as a 510(k) premarket notification, with a decision dated Jun 22, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Anesthesiology
- Decision date
- Jun 22, 2026
Regulatory record facts
- Identifier
- K253148
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Vivaquant, Inc. Dba Rhythm Express
- Product code
- MNR
- Decision code
- SESE
- Decision date
- Jun 22, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Ventilatory Effort Recorder.
- Applicant
- Vivaquant, Inc. Dba Rhythm Express
- Product code
- MNR
- FDA device class
- 2
FDA decision timeline
K253148 received
Application receipt date recorded by FDA.
K253148 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code MNR
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| CNSAC Medshop GmbH | 510(k) clearance | Sep 24, 2026 | FDA | |
WatchPAT SWK254042 | Itamar Medical , Ltd. | 510(k) clearance | Jul 31, 2026 | FDA |
WRAP SystemK260050 | Huneo, LLC | 510(k) clearance | Jul 15, 2026 | FDA |
CASSIEK252628 | Wesper, Inc. | 510(k) clearance | Apr 27, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Vivaquant, Inc. Dba Rhythm Express
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Arden Hills, MN
Sources and methodology
- Original FDA record: K253148
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 21, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records

